Sky-High Prices For Orphan Drugs Slam American Families And Insurers | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/17/sky-high-prices-for-orphan-drugs-slam-american-families-and-insurers/

This investigation examines the booming orphan drug business and how drugmakers have rushed into the marketplace with hundreds of drugs for rare diseases, helping patients while landing lucrative federal incentives and monopoly control for every drug that gets approved. In This Series: The Orphan ‘Monopoly’ Game Coming Next: Saving… http://internationalnewslive.com/sky-high-prices-for-orphan-drugs-slam-american-families-and-insurers/